Trials / Unknown
UnknownNCT05152498
Fu Zheng Jie Du Hua Yu Principle For Treatment Of Severe HBV Related Hepatocellular Carcinoma (FZJDHYPFTOSHBVHCC)
Forming a Comprehensive Treatment Plan for the Treatment of Hepatitis B Virus Related Hepatocellular Carcinoma With the Core Principles of Fuzheng Jiedu Huayu
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 142 (estimated)
- Sponsor
- Beijing Ditan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The treatment of HBV related hepatocellular carcinoma has always been a worldwide problem. The aim of this study is to alleviate the progression of hepatitis B related hepatocellular carcinoma by the Chinese medicine "Fu Zheng Jie Du Hua Yu" Principle.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fu Zheng Jie Du Hua Yu therapy | Fu Zheng Jie Du Hua Yu is a Chinese herbal compound |
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
- First posted
- 2021-12-09
- Last updated
- 2021-12-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05152498. Inclusion in this directory is not an endorsement.